In Focus
Europe must be able both to develop the medicines of the future and to ensure that patients have access to them. This is the starting point for Danish MEP Stine Bosse’s work on the EU’s upcoming Biotech Act, where, as Renew Europe’s lead negotiator, she wants to go further than the European Commission’s proposal.
EU Biotech Act's lead negotiator: “It's now or never”
The EU's proposed Biotech Act does not go far enough, according to Danish MEP Stine Bosse. As a lead negotiator, she wants stronger incentives for European biotech and a single route to ethical approval for cross-border clinical trials – particularly those involving patients with rare diseases.
Advertisement
BREAKING